Restart Life Sciences Corp.
HEAL
Rang in Aktien
#35861
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Aktienkurs
$0.0497946
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$3.11M
Veränderung (1 Tag)
-3.08%
Veränderung (1 Jahr)
73.34%
Land
CA
Handel Restart Life Sciences Corp. (HEAL)
Kategorie
Healthcare
Kursverlauf für Restart Life Sciences Corp. (HEAL)
Höchster Schlusskurs: $0.02 am 2024-11-01
Niedrigster Schlusskurs: $43.29 am 2006-09-01
Niedrigster Schlusskurs: $43.29 am 2006-09-01
Kursverlauf der Aktie von Restart Life Sciences Corp. von 2006 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | -75.42% |
| 2023 | -70.35% |
| 2022 | 0.09% |
| 2021 | -76.14% |
| 2020 | 34.36% |
| 2019 | -45.75% |
| 2018 | -79.87% |
| 2017 | 288.11% |
| 2016 | 333.30% |
| 2015 | 1.17% |
| 2014 | -47.74% |
| 2013 | -50.83% |
| 2012 | -85.77% |
| 2011 | -17.65% |
| 2010 | -44.42% |
| 2009 | -3.55% |
| 2008 | -53.46% |
| 2007 | -59.30% |
| 2006 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
